Recent Advances in Human Papillomavirus Detection and Genotyping

References (93)

1. 1 [21] Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction [DOI]
2. 2 A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. [DOI]
3. 3 Understanding and using sensitivity, specificity and predictive values [DOI]
4. 4 A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. [DOI]
5. 5 The Polymerase Chain Reaction [DOI]
6. 6 Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm [DOI]
7. 7 Novel Short-Fragment PCR Assay for Highly Sensitive Broad-Spectrum Detection of Anogenital Human Papillomaviruses [DOI]
8. 8 Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors [DOI]
9. 9 PCR Technology: Principles and Applications for DNA Amplification
10. 10 Human papillomavirus 16 load in normal and abnormal cervical scrapes: An indicator of CIN II/III and viral clearance [DOI]
11. 11 The molecular genetics of cervical carcinoma [DOI]
12. 12 The frequency of Pap smear screening in the United States [DOI]
13. 13 Viral load as a predictor of the risk of cervical intraepithelial neoplasia [DOI]
14. 14 Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells [DOI]
15. 15 Disruption of the E1 and E2 Reading Frames of HPV 16 in Cervical Carcinoma Is Associated with Poor Prognosis [DOI]
16. 16 Visual inspection as a cervical cancer screening method in a primary health care setting in Africa [DOI]
17. 17 Comparison of the Digene HC2 Assay and the Roche AMPLICOR Human Papillomavirus (HPV) Test for Detection of High-Risk HPV Genotypes in Cervical Samples [DOI]
18. 18 Type-Specific Multiple Sequencing Primers [DOI]
19. 19 Serial type‐specific human papillomavirus ( HPV ) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections [DOI]
20. 20 Validation of human papillomavirus genotyping by signature DNA sequence analysis [DOI]
21. 21 Development and Evaluation of a Liquid Bead Microarray Assay for Genotyping Genital Human Papillomaviruses [DOI]
22. 22 Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. [DOI]
23. 23 Human Papillomavirus Type 16 and Early Cervical Neoplasia [DOI]
24. 24 CONDYLOMATOUS LESIONS OF THE CERVIX. II. CYTOLOGIC, COLPOSCOPIC AND HISTOPATHOLOGIC STUDY [DOI]
25. 25 Physical Status and Expression of HPV Genes in Cervical Cancers [DOI]
26. 26 Separation and detection of DNA by capillary electrophoresis [DOI]
27. 27 Polymerase chain reaction‐based fluorescent Luminex assay to detect the presence of human papillomavirus types [DOI]
28. 28 Comparison of human papillomavirus genotypes in high-grade squamous intraepithelial lesions and invasive cervical carcinoma: evidence for differences in biologic potential of precursor lesions [DOI]
29. 29 Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR [DOI]
30. 30 High-throughput genotyping of high-risk HPV by the digene HPV Genotyping LQ Test using GP5+/6+-PCR and xMAP technology [DOI]
31. 31 Comparison of visual inspection of cervix and Pap smear for cervical cancer screening.
32. 32 Development and evaluation of a PCR and mass spectroscopy (PCR–MS)-based method for quantitative, type-specific detection of human papillomavirus [DOI]
33. 33 Comparison of Abbott RealTime High Risk HPV and Hybrid Capture 2 for the detection of high-risk HPV DNA in a referral population setting [DOI]
34. 34 Cancer du col utérin [DOI]
35. 35 Clinical Laboratory Experience with Cervista HPV HR as a Function of Cytological Classification: Comparison with Retrospective digene HC2 High-Risk HPV DNA Test Data [DOI]
36. 36 Rapid separation of DNA restriction fragments using capillary electrophoresis [DOI]
37. 37 Human papillomavirus detection by hybrid capture and its possible clinical use. [DOI]
38. 38 Detection of CIN by naked eye visualization after application of acetic acid.
39. 39 Molecular tests for human papillomavirus (HPV), Chlamydia trachomatis and Neisseria gonorrhoeaein liquid-based cytology specimen [DOI]
40. 40 Oncogenic human papillomavirus genotyping by multiplex PCR and fragment analysis [DOI]
41. 41 Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction [DOI]
42. 42 Are Papanicolaou smears enough? Acetic acid washes of the cervix as adjunctive therapy: a HARNET study. Harrisburg Area Research Network.
43. 43 Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear [DOI]
44. 44 Papillomavirus infection of the lower genital tract: Detection of viral DNA in gynecological swabs [DOI]
45. 45 Identification of Human Papillomavirus DNA in Cervical and Vaginal Intraepithelial Neoplasia with Molecularly Cloned Virus-Specific DNA Probes [DOI]
46. 46 Detection of Human Papillomavirus DNA by the Nucleic Acid Sandwich Hybridization Method From Cervical Scraping [DOI]
47. 47 Optimization of human papillomavirus genotype detection in cervical scrapes by a modified filter in situ hybridization test [DOI]
48. 48 Qualitative and Quantitative DNA and RNA Analysis by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry [DOI]
49. 49 Molecular Detection of Human Viral Pathogens [DOI]
50. 50 The Management of Cervical Intraepithelial Neoplasia (Squamous) [DOI]
51. 51 PCR protocols — A guide to methods and applications [DOI]
52. 52 Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer [DOI]
53. 53 Human papillomavirus and cervical cancer [DOI]
54. 54 The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR [DOI]
55. 55 Improved Amplification of Genital Human Papillomaviruses [DOI]
56. 56 Overview of the European and North American studies on HPV testing in primary cervical cancer screening [DOI]
57. 57 Against which human papillomavirus types shall we vaccinate and screen? the international perspective [DOI]
58. 58 Viruses in Human Cancers [DOI]
59. 59 A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings [DOI]
60. 60 Bead-Based Multiplex Genotyping of Human Papillomaviruses [DOI]
61. 61 PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems [DOI]
62. 62 Detection and Typing of Human Papillomavirus in Archival Cervical Cancer Specimens by DNA Amplification With Consensus Primers [DOI]
63. 63 The Use of General Primers in the Polymerase Chain Reaction Permits the Detection of a Broad Spectrum of Human Papillomavirus Genotypes [DOI]
64. 64 Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes.
65. 65 Incidence, Duration, and Determinants of Cervical Human Papillomavirus Infection in a Cohort of Colombian Women with Normal Cytological Results [DOI]
66. 66 A review of methods for detect human Papillomavirusinfection [DOI]
67. 67 Evaluation of the SPF 10 -INNO LiPA Human Papillomavirus (HPV) Genotyping Test and the Roche Linear Array HPV Genotyping Test [DOI]
68. 68 Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study [DOI]
69. 69 General primer‐mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas [DOI]
70. 70 Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell line SiHa [DOI]
71. 71 Analysis of Human Papillomavirus Type 16 (HPV16) DNA Load and Physical State for Identification of HPV16-Infected Women with High-Grade Lesions or Cervical Carcinoma [DOI]
72. 72 Comparison of pap smear, visual inspection with acetic acid, human papillomavirus DNA‐PCR testing and cervicography [DOI]
73. 73 Clinical Performance of the PreTect HPV-Proofer E6/E7 mRNA Assay in Comparison with That of the Hybrid Capture 2 Test for Identification of Women at Risk of Cervical Cancer [DOI]
74. 74 A Comparison of 3 Ways of Conventional Pap Smear, Liquid-Based Cytology and Colposcopy vs Cervical Biopsy for Early Diagnosis of Premalignant Lesions or Cervical Cancer in Women with Abnormal Conventional Pap Test [DOI]
75. 75 Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories [DOI]
76. 76 The Laboratory Diagnosis of Genital Human Papillomavirus Infections [DOI]
77. 77 Antibodies Against the Human Papillomavirus Type 16 Early Proteins in Human Sera: Correlation of Anti-E7 Reactivity With Cervical Cancer [DOI]
78. 78 Screening for cervical neoplasia in a developing country utilizing cytology, cervicography and the acetic acid test [DOI]
79. 79 Human Papillomavirus Genotyping by the DNA Chip in the Cervical Neoplasia [DOI]
80. 80 Rapid, sensitive, type specific PCR detection of the E7 region of human papillomavirus type 16 and 18 from paraffin embedded sections of cervical carcinoma [DOI]
81. 81 Detection and genotyping of human papillomavirus by real-time PCR assay [DOI]
82. 82 Comparison of the PapilloCheck® assay with the digene HC2 HPV DNA assay for the detection of 13 high‐risk human papillomaviruses in cervical and anal scrapes [DOI]
83. 83 Comparison of Commercial Hybridization and Automated Transcription-Mediated Amplification Modalities for Detection of High-Risk Human Papillomavirus Nucleic Acid [DOI]
84. 84 Current Problems and Recent Advances in the Molecular Diagnosis of Genital Human Papillomavirus Infections [DOI]
85. 85 Viral Particles in Cervical Condylomatous Lesions [DOI]
86. 86 Molecular Quality of Exfoliated Cervical Cells: Implications for Molecular Epidemiology and Biomarker Discovery [DOI]
87. 87 Serological assays for the detection of HPV antibodies.
88. 88 High Level of Correlation of Human Papillomavirus-16 DNA Viral Load Estimates Generated by Three Real-time PCR Assays Applied on Genital Specimens [DOI]
89. 89 Capillary Electrophoretic Restriction Fragment Length Polymorphism Patterns for the Mycobacterial hsp65 Gene [DOI]
90. 90 Biotargets of Cancer in Current Clinical Practice [DOI]
91. 91 Inter‐laboratory variation as an explanation for varying prevalence estimates of human papillomavirus infection [DOI]
92. 92 Immunoperoxidase demonstration of human papilloma virus (HPV) in dysplastic lesions of the uterine cervix [DOI]
93. 93 Detection and Quantitation of HPV Gene Expression Using Real-Time PCR [DOI]

Cited by 3

Showing 2 of 3 known citations — external sources report more than can currently be individually listed.

Related research

• Breast Self Examination and Cancer Awareness among Female Staff in Federal Medical Center, Yenagoa, Bayelsa State (Knowledge and Practice) — shares topic coverage
• Detection of Elements of Transmission of Zoonotic Diseases in Kolwezi — shares topic coverage
• Detection of Common Transgenic Elements from Soy Sauce Samples by PCRs — shares topic coverage
• Molecular Detection of Ugandan Passiflora Virus Infecting Passionfruit (Passiflora edulis sims) in Rwanda — shares topic coverage
• Application of Artificial Neural Networks for Early Detection of Diabetes Mellitus: Insights from a Case Study in Kaura Namoda Nigeria — shares topic coverage